Biosensors   

Is Biosensors a good buy?

In the 9months to Sept 2007, JWMS reported net profit of US$11mil.

Weigao chose to sell this profit making body to BIG for a 10% stake in BIG (a company with clearly poorer financial performance).

Why did they do that? This qtn was asked in the analyst briefing and anwered by Weigao chairman. BIG supporters here will know what the answer will be. P seems to only understand "T+5", and hence may not understand why Weigao is making this sale and hence he should go and listen to the recording.

 

I believe BIG will be putting in to SGX to lift the Trading Halt after lunch which is 2pm.  From the current mkt queue, I dun think there will be a gap up on the price.  I hope I'm wrong......but this piece of announcement is definitely a window dressing for the coming CE announcement.....  Any moment liao............

 

CHEONG AH........................

 

halt, i thought ce mark but onli aquistion of more share of jw, no money wanna spent more money. let see it cheong up or down, today t+5.

 

When will the halt be lifted? when can i start buying?

 

Bio shares now valued at $1.08.

 



0444 GMT [Dow Jones] Biosensors (B20.SG) may edge up on resuming trade on hopes company''s expansion in China through proposed buyout of rest of 50%-owned JW Medical Systems will boost bottomline. Overall market weakness may limit any upside. Drug-eluting stent maker offering to buy initial 30% stake from Shandong Weigao Group (8199.HK) for S$129.6 million through 120 million new shares at S$1.08 each. This will result in Weigao owning 10.2% of Biosensors post-sale; seller has pledged not to offload Biosensors shares for 6 months from completion of deal. Company has also secured option to buy remaining 20% stake from Weigao which will be funded through 40 million shares. Deal may help Biosensors pare losses (incurred net loss of US$36.3 million in fiscal FY07); company tips loss per share to fall to 2.35 U.S. cents post-sale vs loss of 3.99 U.S. cents currently. JW Medical, which also makes similar stents, earned net profit of US$11.1 million for first 9 months of 2007. Stock halted since morning, last closed at S$0.905. No mention yet of when trading will resume. (FKH)

 

Any idea when they are lifting the trading halt? Thks

 

congra to all vested...sold mine few day back...good luck to all ..Biosensor alway surprise..esp in today market we need them...congra to all..

 

Let's just sit tight on this hot Biosensors. I love it when a spate of news comes out. I guess Biosensors is really improving their PR nowadays.

Anyway, STI rebounding up now. Just ride along.

Everyone has their own bullish or bearish views, no need to get too worked up :-). Just trade with your analysis, faith AND mkt trend and monitor. Let the profit/loss statement be your judge.

 

 

Biosensors Announces Agreement to Acquire Remaining Stake in

JW Medical Systems

Singapore, 9 January 2008 ?

?Biosensors?) and Shangdong Weigao Group Medical Polymer Company Limited (Hong

Kong Stock Exchange: 8199, ?Weigao?) today announced that they have entered into

agreements for Biosensors to acquire an additional 30 percent interest in JW Medical

Systems Ltd. (?JW Medical?) and to grant Weigao an option to sell to Biosensors the

remaining 20 percent interest in JW Medical by 30 July 2009. The acquisition of the

further stake in JW Medical will enable Biosensors to establish a stronger presence in

China following its acquisition of the first 50 percent interest in JW Medical in

September 2007.

Yoh Chie Lu, Chairman and CEO of Biosensors said, ?This acquisition symbolizes a mutual

commitment between Biosensors and Weigao to forge stronger relationships as longterm

strategic partners in Asia. The demand for drug-eluting stents continues to grow

rapidly in China and having ownership of JW Medical will place us in a strong position to

create maximum traction in this important and large market. Additionally, with Weigao

now as a strategic shareholder of Biosensors, we will be able to leverage on its strength

to become a leader in Asia, particularly in China.?

?Since commercialization of its drug-eluting stent in early 2006, JW Medical has

demonstrated operational excellence and has successfully increased its production

capacity to meet rapidly growing demands. We can certainly leverage this experience as

we prepare ourselves for commercialization of our BioMatrix® drug-eluting stent. For

the nine months ended 30 September 2007, JW Medical reported an impressive net

profit of US$11.1 million which is about three times the net profit of US$3.8 million

earned in the initial nine months after commercialization of its drug-eluting stent. With

completion of the acquisition, we expect JW Medical not only to add sales to our top

line but also contribute positively to our profit line when its financial results are

consolidated with ours.? Mr. Lu added.

Mr. Lu further commented, ?Apart from the accretive impact of its financial results, JW

Medical can also augment our existing resources and expand our operational capability,

capacity, and distribution. Through JW Medical and Weigao, we are definitely better

able to introduce our future technologies into the China market and develop strategies

that can capitalize on the growth potential there.?

After the required approvals are obtained, Biosensors will issue 120 million of its

ordinary shares to Weigao in exchange for 30 percent of JW Medical. Biosensors will

issue another 40 million of its ordinary shares if Weigao exercises its option to sell the

remaining 20 percent of JW Medical to Biosensors.

Mr. Chen Xue Li, Chairman of Weigao group said, ?China certainly offers explosive

growth opportunities for companies with innovative technology and operational

excellence. As shareholders of Biosensors now, we can leverage on Biosensors?

leadership in interventional cardiology and enable Weigao to become a leader in the

medical device industry in Asia. At the same time, we can also work closely with

Biosensors and by utilizing our strengths in sales and marketing and knowledge of the

Chinese market we can bring Biosensors? new products and technology into the fastgrowing

market in China more effectively and efficiently. We look forward to becoming

a long-term shareholder and strategic partner of Biosensors to grow the business

beyond China as well.?

Under the agreement, Weigao also has the right to purchase up to 20 million additional

new ordinary shares in cash, at a price to be negotiated, within 60 days from the date of

the agreement. Weigao will own approximately 14.6 percent of the total outstanding

shares of Biosensors assuming the issuance of an aggregate 160 million ordinary shares

upon completion of the acquisition of the remaining 50 percent equity interest of JW

Medical and the further purchase of 20 million new shares by Weigao.

Mr. Lu further commented, ?I am very pleased that execution of these agreements will

have two positive impacts on Biosensors. First, we will quickly establish ourselves in

China through the ownership of a high-quality company such as JW Medical. Second, in

this process, we have managed to develop a stronger alliance with Weigao, a highlyreputable

company that can together with us, leverage on mutual strengths to create

greater shareholder value for both companies.?

Biosensors has submitted statutory filings related to this acquisition to the Singapore

Exchange and which are also available at Biosensors? corporate website atBiosensors International Group, Ltd. (Bloomberg: BIG SP,

www.biosensors.com under the Investor Relations section.

 

I dun think I wish to know what's under Elite's P card, CAN'T BE BOTHERED! Stop playing with Monopoly $$, it's REAL $$ we are dealing with! Wake Up! Sometimes I just hope BIG will halt for trading until CE approval end of this month. Let the Katek panic for the next 3 weeks and then die pain pain when trading halt lifted!

 

BIG has been on Hold this morning after trading for a couple of hrs. It  could be bad or good news but seems like good news overweigh the bad one. Hope so as I added another 10 lots at .91cent to my portfolio. Cheers for the DHL Shusi. More good yrs.

 

Biosensors Announces Agreement to Acquire Remaining Stake in

JW Medical Systems

 

Bengster68, why do you continue to engage Pension? It's obvious he's out to irritate everyone.

Knn Pension, can trade quietly or not.

 

Maybe ganna check???

 

Tan-All-In Member	Posted: 09-Jan-2008 12:13
x 0 x 0	My guess is JV with india distribuution power-house

It could be. But last week BIG just announced they set up an India subsidiary so it may not be about India JV. I think it could be some Asian country collaboration again.

 

Sushi will be served after CE, not before.

Pension Elite	Posted: 09-Jan-2008 12:08
x 0 x 0	playing share is like playing poker, once ppl see your expression, u are finish. i am going to collect his stamp at a very low price, current price is overvalue and overbought.

It was because this stock was over-sold, grossly undervalued and too unappreciated by investors previously. Take out the CE uncertainty, add in profit visibility, you will see a change in market sentiment of this stock

 

My guess is JV with india distribuution power-house

 

playing share is like playing poker, once ppl see your expression, u are finish. i am going to collect his stamp at a very low price, current price is overvalue and overbought.

 

The situation and fundamentals of BIG has never look as bright as before. This company has generally performed "reasonably ok" previously. In fact, they scored full marks in terms of clinical trials performance and that is the most important factor for small biomedical companies like BIG. CE delay is the only area BIG performed very badly but BIG has no control over CE approval and clinical rials has been very excellent (best DES the world has seen so far). It is because of CE delay that this company is running at a loss. However, general poor market sentiment and lack of investors' understanding in BIG's real potential are also factors causing weak share price.  

 

bb is waiting to short it down.